Single Cell Genome Sequencing Market Trends Estimates High Demand By 2026 With Key Companies Illumina Inc., Fludigim Corporation, Thermo Fisher Scientific, F. Hoffmann La Roche Ltd., Inc. QIAGEN

Single cell genome sequencing involves isolating a single cell and amplifying and sequencing genes within that single cell. Sequencing single cell carries significant importance as individual cells can differ at great extent in size, protein levels, and expressed RNA transcripts. These variations could provide important insights about several research applications such as cancer research, stem cell biology, immunology, developmental biology, and neurology. Single-cell analysis enables a closer view of the gene expression of individual cells to understand their functions in complex tissues.

Get PDF Brochure of Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/2059

Kits and instruments based on technological platform such as Next Generation Sequencing (NGS), polymerase chain reaction (PCR), quantitative polymerase chain reaction (qPCR), and others provide high-throughput sequencing of individual cells. Single cell sequencing has significantly evolved with in-depth understanding of genomes and increasing genomic research to trace the root cause of many chronic diseases.

Application of single cell genomic sequencing in other diseases such as immune system disorder and infectious diseases (Tuberculosis, meningococcal disease, and others.) is a key factor contributing to the market growth. According to statistics given by Centers for Disease Control and Prevention 2017 Vital Signs, around 54.4 million U.S. adults suffer from arthritis – which is equivalent to 25% of the U.S. population. Rheumatoid arthritis which is leading autoimmune disorder holds significant share in the overall arthritis prevalence.

Continuous development in sequencing technologies is further expected to propel growth of the single cell genome sequencing market. PCR and next generation sequencing are rapidly emerging as preferred technology for several applications including single cell genomic sequencing. For instance, Oxford Nanopore, in 2017, launched two sequencing kits— for direct or PCR cDNA analysis that facilitate easy use and provide results in reduced time and cost. Several collaborations amongst commercial companies and academic and research institutes is expected to propel the single cell genome sequencing market growth.

Single Cell Genome Sequencing Market - "Competitive Landscape"

Key players operating in the single cell genome sequencing market include, Illumina, Inc., Fludigim Corporation, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Inc., QIAGEN, Bio-Rad Laboratories, 10x Genomics, Novogene, BGI, Oxford Nanopore Technologies, and Pacific Biosciences

Request For Customization Of This Report : https://www.coherentmarketinsights.com/insight/request-customization/2059

Companies are focused on new product launches and collaborations to extend their market share. For instance,

In January 2018, Illumina launched semiconductor-based sequencing system—iSeq 100t that uses sequencing-by-synthesis chemistry coupled with CMOS detection technology.

In June 2018, QIAGEN launched QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit with a new generation of reagents that enables the most accurate microbial community profiling from complex microbiome samples and is used for single cell sequencing.

"Single Cell Genome Sequencing Market Taxonomy"

On the basis of product type:
Kits and Reagents
Instruments

On the basis of technology:
Next Generation Sequencing
PCR
qPCR
Microarray
MDA
Others

On the basis of end users:
Research and Academic Institutes
Sequencing laboratories
Pharmaceutical and Biotech Companies
Others

On the basis of geography:
North America
Latin America
Europe
Asia Pacific
Middle East
Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.